• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP HAV TOTAL (AHAVT) ASSAY; HEPATITIS A VIRUS (ANTI-HAV) ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP HAV TOTAL (AHAVT) ASSAY; HEPATITIS A VIRUS (ANTI-HAV) ASSAY Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/01/2016
Event Type  malfunction  
Manufacturer Narrative
The cause for the (b)(6) patient results compared to an alternate method is unknown.The customer's quality control results were acceptable at the time of the testing.Siemens is investigating this incident and has requested the patient samples for investigation.Advia centaur (b)(4) reagent lot 073182; date of manufacture 06-30-2016; expiration date 06-30-2017; udi - to be provided.
 
Event Description
Customer reported that they are observing (b)(6) results with the advia centaur (b)(4) assay.The results do not agree with an alternate method.There are no reports that treatment was altered or prescribed based on the advia centaur xp (b)(6) results.
 
Manufacturer Narrative
Siemens filed mdr 1219913-2017-00015 on february 9, 2017 reporting a number of (b)(6) samples with the advia centaur xp hav total (ahavt) assay that did not agree with an alternate method.March 7, 2017 additional information: siemens evaluated the standardization of the advia centaur xp ahavt in comparison to who standardization and found that who standards and master curve standards are close to target.The 2pt calibration results are biased high compared to the who standards and master curve standards.Siemens also identified that internal controls are running outside of internal ranges.Siemens continues to investigate the issue.
 
Manufacturer Narrative
Siemens filed mdr 1219913-2017-00015 on february 9, 2017 reporting a number of (b)(6) samples with the advia centaur xp (b)(6) assay that did not agree with an alternate method.Mdr 1219913-2017-00015 supplemental 1, was filed on march 7, 2017 with additional information regarding the investigation.February 14, 2018 - additional information: siemens' investigation showed that all specifications are met; however a two-point calibration bias to the internal master curve and a higher bias to who material than what has been historically observed was seen with reagent lot 104077 and the sister lot 073182 which expired june 30, 2017.These biases could manifest as an increase in the number of positive sample results.Additionally, siemens reviewed siemens real time solutions (srs) data.This data shows a higher percentage of patients above the assay cutoff with reagent lot 104077 (073182) than seen with other reagent lots.The bias and the increase in the number of (b)(6) sample results are limited to this reagent lot(s).Siemens determined that the increase in the number of (b)(6) sample results was not due to a shipping or handling issue with the reagents as reagents returned to siemens performed similarly to siemens' retains.Root cause was not able to be determined prior to lot expiration and the issue does not appear to be a systemic (b)(6) total problem.Although root cause has not been identified and the product met all specifications, siemens is evaluating opportunities for process improvements to reduce the potential that future lots would exhibit similar performance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP HAV TOTAL (AHAVT) ASSAY
Type of Device
HEPATITIS A VIRUS (ANTI-HAV) ASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
tarrytown NY 10591
MDR Report Key6313976
MDR Text Key67388015
Report Number1219913-2017-00015
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
PMA/PMN Number
P040017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Remedial Action Inspection
Type of Report Initial,Followup,Followup
Report Date 03/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/09/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/25/2017
Device Model NumberN/A
Device Catalogue Number10322676
Device Lot Number073180
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received02/14/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-